2014 Q4 Form 10-K Financial Statement

#000143774916024657 Filed on February 03, 2016

View on sec.gov

Income Statement

Concept 2014 Q4 2014 2013 Q4
Revenue $8.880M $36.17M $7.210M
YoY Change 23.16% 5.68% 4.04%
Cost Of Revenue $6.530M $27.45M $5.510M
YoY Change 18.51% 6.13% 11.31%
Gross Profit $2.350M $8.725M $1.700M
YoY Change 38.24% 4.28% -13.71%
Gross Profit Margin 26.46% 24.12% 23.58%
Selling, General & Admin $1.620M $6.578M $1.320M
YoY Change 22.73% 8.99% 29.41%
% of Gross Profit 68.94% 75.39% 77.65%
Research & Development $120.0K $191.0K $130.0K
YoY Change -7.69% 9.77% 44.44%
% of Gross Profit 5.11% 2.19% 7.65%
Depreciation & Amortization $280.0K $907.0K $140.0K
YoY Change 100.0% 28.84% -33.33%
% of Gross Profit 11.91% 10.4% 8.24%
Operating Expenses $1.740M $7.060M $1.450M
YoY Change 20.0% 7.79% 30.63%
Operating Profit $610.0K $1.665M $250.0K
YoY Change 144.0% -8.38% -70.93%
Interest Expense -$80.00K $351.9K -$70.00K
YoY Change 14.29% 18.63% -12.5%
% of Operating Profit -13.11% 21.14% -28.0%
Other Income/Expense, Net -$60.00K -$362.3K $0.00
YoY Change -193.22% -100.0%
Pretax Income $470.0K $1.303M $190.0K
YoY Change 147.37% -40.95% -76.25%
Income Tax $80.00K $367.3K -$10.00K
% Of Pretax Income 17.02% 28.2% -5.26%
Net Earnings $380.0K $935.2K $190.0K
YoY Change 100.0% -39.72% -66.07%
Net Earnings / Revenue 4.28% 2.59% 2.64%
Basic Earnings Per Share $0.23
Diluted Earnings Per Share $93.83K $0.23 $39.67K
COMMON SHARES
Basic Shares Outstanding 4.048M
Diluted Shares Outstanding 4.053M

Balance Sheet

Concept 2014 Q4 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $510.0K $510.0K $210.0K
YoY Change 142.86% 142.86% -86.45%
Cash & Equivalents $511.7K $208.0K
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $125.2K $1.390M $242.1K
YoY Change -48.28% -5.44% -82.33%
Inventory $15.09M $15.11M $14.92M
Prepaid Expenses
Receivables $2.962M $2.960M $3.000M
Other Receivables $100.0K $100.0K $110.0K
Total Short-Term Assets $20.07M $20.07M $19.75M
YoY Change 1.59% 1.62% -1.88%
LONG-TERM ASSETS
Property, Plant & Equipment $11.68M $11.74M $11.90M
YoY Change -1.84% -2.33% 20.2%
Goodwill $993.7K $993.7K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $47.36K $50.00K $0.00
YoY Change -100.0%
Total Long-Term Assets $12.78M $12.78M $13.02M
YoY Change -1.81% -1.84% 17.26%
TOTAL ASSETS
Total Short-Term Assets $20.07M $20.07M $19.75M
Total Long-Term Assets $12.78M $12.78M $13.02M
Total Assets $32.85M $32.85M $32.77M
YoY Change 0.24% 0.24% 4.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $874.7K $870.0K $806.2K
YoY Change 8.49% 7.41% 24.03%
Accrued Expenses $1.584M $1.580M $1.718M
YoY Change -7.81% -8.14% -12.32%
Deferred Revenue
YoY Change
Short-Term Debt $2.570M $2.570M $3.350M
YoY Change -23.28% -23.28%
Long-Term Debt Due $1.284M $1.280M $1.229M
YoY Change 4.47% 4.07% 5.04%
Total Short-Term Liabilities $6.504M $6.500M $7.269M
YoY Change -10.53% -10.59% 21.96%
LONG-TERM LIABILITIES
Long-Term Debt $5.949M $5.950M $6.252M
YoY Change -4.84% -4.8% -14.36%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.949M $5.950M $6.252M
YoY Change -4.84% -4.8% -14.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.504M $6.500M $7.269M
Total Long-Term Liabilities $5.949M $5.950M $6.252M
Total Liabilities $13.59M $13.59M $14.47M
YoY Change -6.07% -6.08% 2.21%
SHAREHOLDERS EQUITY
Retained Earnings $16.57M $15.64M
YoY Change 5.98%
Common Stock $40.49K $40.47K
YoY Change 0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.25M $19.25M $18.29M
YoY Change
Total Liabilities & Shareholders Equity $32.85M $32.85M $32.77M
YoY Change 0.24% 0.24% 4.92%

Cashflow Statement

Concept 2014 Q4 2014 2013 Q4
OPERATING ACTIVITIES
Net Income $380.0K $935.2K $190.0K
YoY Change 100.0% -39.72% -66.07%
Depreciation, Depletion And Amortization $280.0K $907.0K $140.0K
YoY Change 100.0% 28.84% -33.33%
Cash From Operating Activities $2.820M $1.942M -$700.0K
YoY Change -502.86% -82941.51% -125.09%
INVESTING ACTIVITIES
Capital Expenditures $20.00K $633.1K -$160.0K
YoY Change -112.5% -24.82% -40.74%
Acquisitions
YoY Change
Other Investing Activities $20.00K $20.00K -$3.020M
YoY Change -100.66% -100.8%
Cash From Investing Activities $30.00K -$617.2K -$3.180M
YoY Change -100.94% -81.54% 1123.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.248M
YoY Change 2.81%
Cash From Financing Activities -2.580M -1.021M 2.660M
YoY Change -196.99% -150.88% -301.52%
NET CHANGE
Cash From Operating Activities 2.820M 1.942M -700.0K
Cash From Investing Activities 30.00K -617.2K -3.180M
Cash From Financing Activities -2.580M -1.021M 2.660M
Net Change In Cash 270.0K 303.8K -1.220M
YoY Change -122.13% -122.69% -200.83%
FREE CASH FLOW
Cash From Operating Activities $2.820M $1.942M -$700.0K
Capital Expenditures $20.00K $633.1K -$160.0K
Free Cash Flow $2.800M $1.309M -$540.0K
YoY Change -618.52% -254.98% -117.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015Q4 artw Assets Held For Lease
AssetsHeldForLease
CY2014Q4 artw Assets Held For Lease
AssetsHeldForLease
58500
CY2015 artw Defined Contribution Plan Minimum Threshold Percentage Of Employee Contributions
DefinedContributionPlanMinimumThresholdPercentageOfEmployeeContributions
0.04
CY2015 artw Engineering Expense
EngineeringExpense
500820
CY2014 artw Engineering Expense
EngineeringExpense
482057
CY2015Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Maximum Inventory Amount
LineOfCreditFacilityBorrowingCapacityBorrowingBaseMaximumInventoryAmount
6000000
CY2015Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Minimum Percentage Of Aggregate Receivables
LineOfCreditFacilityBorrowingCapacityBorrowingBaseMinimumPercentageOfAggregateReceivables
0.2
CY2015Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Percentage Of Accounts Receivable
LineOfCreditFacilityBorrowingCapacityBorrowingBasePercentageOfAccountsReceivable
0.75
CY2015Q4 artw Line Of Credit Facility Borrowing Capacity Borrowing Base Percentage Of Inventory
LineOfCreditFacilityBorrowingCapacityBorrowingBasePercentageOfInventory
0.5
CY2015 artw Overdue Trade Receivables Interest Rate Percent Of Account Balances Per Month
OverdueTradeReceivablesInterestRatePercentOfAccountBalancesPerMonth
0.015
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015 dei Trading Symbol
TradingSymbol
artw
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4061052
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-11-30
CY2015 dei Document Type
DocumentType
10-K
CY2015Q2 dei Entity Public Float
EntityPublicFloat
11158555
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1279913
CY2015 artw Standard Product Warranty Term
StandardProductWarrantyTerm
P1Y
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
522400
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
874653
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2057739
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2961834
CY2015Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
86858
CY2014Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
96382
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
447334
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
511716
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
207950
CY2015 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-64381
CY2014 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
303766
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1584328
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13696044
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14838415
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2667010
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2638651
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14504
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28484
CY2015 us-gaap Advertising Expense
AdvertisingExpense
488000
CY2014 us-gaap Advertising Expense
AdvertisingExpense
511000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28484
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14504
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
35175
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
35474
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
18810
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18810
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35175
CY2015 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
11778
CY2014 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4838
CY2015Q4 us-gaap Assets
Assets
31331608
CY2014Q4 us-gaap Assets
Assets
32846342
CY2015Q4 us-gaap Assets Current
AssetsCurrent
19962319
CY2014Q4 us-gaap Assets Current
AssetsCurrent
20065961
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4061052
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4048552
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4061052
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4048552
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
40611
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
40486
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 27pt"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 27pt; VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c)</div></div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash Concentration</div></div></div></div></td> </tr> </table><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 54pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company maintains several different accounts at four different banks, and balances in these accounts are periodically in excess of federally insured limits. However, management believes the risk of loss to be low.</div></div></div></div></div>
CY2015Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
27951
CY2014Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
8048
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20952109
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
27445242
CY2015Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
206672
CY2014Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear
17543
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-126301
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
307452
CY2015Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
166626
CY2014Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
95411
CY2015 us-gaap Debt Instrument Interest Rate Stated Percentage Rate Range Minimum
DebtInstrumentInterestRateStatedPercentageRateRangeMinimum
0.035
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-180919
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
59806
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
21000
CY2014Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
22000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1146242
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1259943
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
126000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
147000
CY2015 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
71215
CY2014 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-52094
CY2015 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
180919
CY2014 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-157089
CY2015 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
245495
CY2014 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-8096
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
999000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1091000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
846960
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1141580
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
847000
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1142000
CY2015Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
110016
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
47466
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
54544
CY2015 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2015 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.01
CY2015 us-gaap Depreciation
Depreciation
929180
CY2014 us-gaap Depreciation
Depreciation
906702
CY2015Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
1245432
CY2014Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
CY2015 us-gaap Dividends Cash
DividendsCash
202432
CY2015Q4 us-gaap Due From Related Parties
DueFromRelatedParties
9600
CY2014Q4 us-gaap Due From Related Parties
DueFromRelatedParties
0
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.355
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.282
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.015
CY2014 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.038
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.02
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
564098
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
673934
CY2015 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2014 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3881
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
20462
CY2014 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
10500
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-123405
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
6268
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4736866
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4205375
CY2015Q4 us-gaap Goodwill
Goodwill
375000
CY2014Q4 us-gaap Goodwill
Goodwill
993729
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
618729
CY2015 us-gaap Gross Profit
GrossProfit
6983682
CY2014 us-gaap Gross Profit
GrossProfit
8724569
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-865062
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1302505
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-307220
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
367258
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
282614
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
299988
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
345912
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
100417
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-352253
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
68447
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-908700
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33529
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-304415
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-134147
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
609804
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
166755
CY2015 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-59308
CY2014 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-69559
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-198653
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
103356
CY2015 us-gaap Interest Expense
InterestExpense
329455
CY2014 us-gaap Interest Expense
InterestExpense
351899
CY2015 us-gaap Interest Paid
InterestPaid
328529
CY2014 us-gaap Interest Paid
InterestPaid
356470
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8204843
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8504062
CY2015Q4 us-gaap Inventory Gross
InventoryGross
18722263
CY2014Q4 us-gaap Inventory Gross
InventoryGross
19008227
CY2015Q4 us-gaap Inventory Net
InventoryNet
15699084
CY2014Q4 us-gaap Inventory Net
InventoryNet
15089280
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10058894
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10037055
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3023179
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3918947
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
458526
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
467110
CY2015Q4 us-gaap Liabilities
Liabilities
12811742
CY2014Q4 us-gaap Liabilities
Liabilities
13594686
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31331608
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32846342
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7338115
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6503777
CY2015Q4 us-gaap Line Of Credit
LineOfCredit
3959656
CY2015Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.035
CY2015Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
8000000
CY2015Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
3026677
CY2015Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3959656
CY2014Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2569106
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
5949329
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
7233226
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1322662
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1283897
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1322662
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
145585
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1947128
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2433938
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4626667
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5949329
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23390957
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26519207
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
234266
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1020831
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-253637
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-617208
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
285035
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-403663
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
1664838
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95779
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1941805
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-557842
CY2014 us-gaap Net Income Loss
NetIncomeLoss
935247
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-461399
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-362333
CY2015 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2015 us-gaap Operating Expenses
OperatingExpenses
7387345
CY2014 us-gaap Operating Expenses
OperatingExpenses
7059731
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
536284
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
676128
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
59336
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
125229
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53944
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
47360
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-131944
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10434
CY2015 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
202432
CY2014 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
292543
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
633078
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1000000
CY2015 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1390550
CY2014 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-780894
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
38906
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
15870
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7760
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
179531
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9694913
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11680792
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-4605
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4539
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1283897
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1247697
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
162000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
191000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15812245
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16572519
CY2015 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
32000
CY2014 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
59000
CY2015 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
634000
CY2014 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
628000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
27935791
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
36169811
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2149659
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2372299
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
28484
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
14504
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
14000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.84
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
14000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.84
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.01574
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3055
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3228
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0325
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0325
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
169000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
155000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.47
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.81
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4020
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
14000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
19000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.84
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.17
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15400
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
160000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
174000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
143000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.72
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.39
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.88
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.70
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.10
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15400
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y208D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y98D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y248D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y51D
CY2014Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
234265
CY2013Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
220719
CY2015Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
179531
CY2015 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
329672
CY2014 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
421787
CY2015 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
274938
CY2014 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
435333
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7760
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
18519866
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
19251656
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
18294145
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 27pt">&nbsp;</td> <td style="WIDTH: 27pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(p)</div></div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div></div></td> </tr> </table><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 54pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 54pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management of the Company has made a number of estimates and assumptions related to the reported amount of assets and liabilities, reported amount of revenues and expenses, and the disclosure of contingent assets and liabilities to prepare these financial statements in conformity with generally accepted accounting principles. Actual results could differ from those estimates. </div></div></div></div></div>
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2014 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4907
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4058382
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4052703
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4058382
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4047796

Files In Submission

Name View Source Status
0001437749-16-024657-index-headers.html Edgar Link pending
0001437749-16-024657-index.html Edgar Link pending
0001437749-16-024657.txt Edgar Link pending
0001437749-16-024657-xbrl.zip Edgar Link pending
artw-20151130.xml Edgar Link completed
artw-20151130.xsd Edgar Link pending
artw-20151130_cal.xml Edgar Link unprocessable
artw-20151130_def.xml Edgar Link unprocessable
artw-20151130_lab.xml Edgar Link unprocessable
artw-20151130_pre.xml Edgar Link unprocessable
artw20151130_10k.htm Edgar Link pending
ex10-59.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending